Table 4.
Study (References) | Case classification | Diabetes | Hypertension | Cardio-vascular disease | Malignancy | Chronic liver disease | COPD | Others (n, %) | Any co-morbidity |
---|---|---|---|---|---|---|---|---|---|
COMORBIDITIES | |||||||||
Huang et al. (25) | |||||||||
ICU cases (n = 13) | 1 (8%) | 2 (15%) | 3 (23%) | 0 | 0 | 1 (8%) | – | 5 (38%) | |
Non-ICU (n = 28) | 7 (25%) | 4 (14%) | 3 (11%) | 1 (4%) | 1 (4%) | 0 | – | 8 (29%) | |
p-value | 0.17 | 0.93 | 0.32 | 0.49 | 0.68 | 0.14 | – | 0.53 | |
Wang et al. (28) | |||||||||
ICU cases (n = 36) | 8 (22.2%) | 21 (58.3%) | 9 (25%) | 4 (11.1%) | 0 | 3 (8.3%) | – | 26 (72%) | |
Non-ICU (n = 102) | 6 (5.9%) | 22 (21.6%) | 11 (10.8%) | 6 (5.9%) | 4 (3.9%) | 1 (1%) | HIV (2.2%) | 38 (37%) | |
p-value | 0.009 | <0.001 | 0.04 | 0.29 | 0.57 | 0.054 | – | <0.001 | |
Author | Case classification | Fever (%) | Cough (%) | Sputum (%) | Shortness of breath (%) | Myalgia (%) |
Malaise/ Fatigue (%) |
Headache (%) | Diarrhea (%) |
SYMPTOMS AT ADMISSION | |||||||||
Huang et al. (25) | |||||||||
ICU (n = 13) | 13(100%) | 11 (85%) | 5(38%) | 12 (92%) | 7 (54%) | 0 | 0 | ||
Non-ICU (n = 28) | 27 (96%) | 20 (71%) | 6 (23%) | 10 (37%) | 11 (39%) | 3 (12%) | 1 (4%) | ||
p-value | 0.68 | 0.35 | 0.32 | 0.001 | 0.38 | 0.10 | 0.66 | ||
Wang et al. (28) | |||||||||
ICU (n = 36) | 36 (100%) | 21 (58%) | 8 (22%) | 23 (64%) | 12 (33%) | 29 (81%) | 3 (8%) | 6 (17%) | |
Non-ICU (n = 102) | 100 (98%) | 61 (60%) | 29 (28%) | 20 (20%) | 36 (35%) | 67 (66%) | 6 (6%) | 8 (8%) | |
p-value | >0.99 | 0.88 | 0.35 | <0.001 | 0.83 | 0.1 | 0.7 | 0.2 |
COPD, Chronic Obstructive Pulmonary Disease.
p-value in bold is statistically significant (<0.05).